NM_024079.5:c.665A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_024079.5(ALG8):​c.665A>G​(p.Asn222Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.216 in 1,613,832 control chromosomes in the GnomAD database, including 39,483 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.18 ( 2910 hom., cov: 33)
Exomes 𝑓: 0.22 ( 36573 hom. )

Consequence

ALG8
NM_024079.5 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.542

Publications

36 publications found
Variant links:
Genes affected
ALG8 (HGNC:23161): (ALG8 alpha-1,3-glucosyltransferase) This gene encodes a member of the ALG6/ALG8 glucosyltransferase family. The encoded protein catalyzes the addition of the second glucose residue to the lipid-linked oligosaccharide precursor for N-linked glycosylation of proteins. Mutations in this gene have been associated with congenital disorder of glycosylation type Ih (CDG-Ih). Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
ALG8 Gene-Disease associations (from GenCC):
  • ALG8-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • polycystic liver disease 3 with or without kidney cysts
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0013854206).
BP6
Variant 11-78114274-T-C is Benign according to our data. Variant chr11-78114274-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 96092.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.23 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALG8NM_024079.5 linkc.665A>G p.Asn222Ser missense_variant Exon 6 of 13 ENST00000299626.10 NP_076984.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALG8ENST00000299626.10 linkc.665A>G p.Asn222Ser missense_variant Exon 6 of 13 1 NM_024079.5 ENSP00000299626.5

Frequencies

GnomAD3 genomes
AF:
0.178
AC:
27115
AN:
152124
Hom.:
2909
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0620
Gnomad AMI
AF:
0.160
Gnomad AMR
AF:
0.231
Gnomad ASJ
AF:
0.300
Gnomad EAS
AF:
0.0927
Gnomad SAS
AF:
0.206
Gnomad FIN
AF:
0.191
Gnomad MID
AF:
0.307
Gnomad NFE
AF:
0.233
Gnomad OTH
AF:
0.197
GnomAD2 exomes
AF:
0.202
AC:
50661
AN:
250942
AF XY:
0.206
show subpopulations
Gnomad AFR exome
AF:
0.0602
Gnomad AMR exome
AF:
0.213
Gnomad ASJ exome
AF:
0.306
Gnomad EAS exome
AF:
0.100
Gnomad FIN exome
AF:
0.180
Gnomad NFE exome
AF:
0.228
Gnomad OTH exome
AF:
0.215
GnomAD4 exome
AF:
0.220
AC:
321515
AN:
1461590
Hom.:
36573
Cov.:
39
AF XY:
0.221
AC XY:
160373
AN XY:
727118
show subpopulations
African (AFR)
AF:
0.0585
AC:
1960
AN:
33478
American (AMR)
AF:
0.216
AC:
9660
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.305
AC:
7961
AN:
26128
East Asian (EAS)
AF:
0.0839
AC:
3328
AN:
39682
South Asian (SAS)
AF:
0.206
AC:
17743
AN:
86252
European-Finnish (FIN)
AF:
0.184
AC:
9804
AN:
53354
Middle Eastern (MID)
AF:
0.261
AC:
1504
AN:
5766
European-Non Finnish (NFE)
AF:
0.231
AC:
256626
AN:
1111826
Other (OTH)
AF:
0.214
AC:
12929
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
13866
27732
41598
55464
69330
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8678
17356
26034
34712
43390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.178
AC:
27122
AN:
152242
Hom.:
2910
Cov.:
33
AF XY:
0.178
AC XY:
13213
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.0618
AC:
2570
AN:
41584
American (AMR)
AF:
0.232
AC:
3543
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.300
AC:
1041
AN:
3470
East Asian (EAS)
AF:
0.0933
AC:
484
AN:
5190
South Asian (SAS)
AF:
0.207
AC:
999
AN:
4824
European-Finnish (FIN)
AF:
0.191
AC:
2019
AN:
10584
Middle Eastern (MID)
AF:
0.289
AC:
85
AN:
294
European-Non Finnish (NFE)
AF:
0.233
AC:
15823
AN:
67996
Other (OTH)
AF:
0.195
AC:
412
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1117
2234
3351
4468
5585
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
296
592
888
1184
1480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.215
Hom.:
12919
Bravo
AF:
0.175
TwinsUK
AF:
0.228
AC:
846
ALSPAC
AF:
0.246
AC:
948
ESP6500AA
AF:
0.0739
AC:
325
ESP6500EA
AF:
0.229
AC:
1967
ExAC
AF:
0.199
AC:
24110
Asia WGS
AF:
0.139
AC:
482
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

ALG8 congenital disorder of glycosylation Benign:5
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 31, 2018
SIB Swiss Institute of Bioinformatics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

This variant is interpreted as a Benign - Stand Alone, for Congenital disorder of glycosylation, type Ih, in Autosomal Recessive manner. The following ACMG Tag(s) were applied: BA1 => Allele frequency is >5% in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:3
Oct 04, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.054
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
11
DANN
Benign
0.33
DEOGEN2
Benign
0.11
T;.;.;T;T;.;.;.
Eigen
Benign
-0.60
Eigen_PC
Benign
-0.44
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.87
D;.;D;D;D;D;D;T
MetaRNN
Benign
0.0014
T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.58
N;N;N;.;.;.;.;.
PhyloP100
0.54
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.42
N;N;.;N;N;N;N;N
REVEL
Benign
0.14
Sift
Benign
0.85
T;T;.;T;T;T;T;T
Sift4G
Benign
0.65
T;T;T;.;.;.;.;.
Polyphen
0.0
B;.;.;.;.;.;.;.
Vest4
0.054
MPC
0.12
ClinPred
0.0056
T
GERP RS
1.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.014
gMVP
0.081
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs665278; hg19: chr11-77825320; COSMIC: COSV55199658; COSMIC: COSV55199658; API